About Eightsix Science
We're a team of neuroengineers and neuroscientists with strong AI backgrounds. The brain cannot regenerate lost tissue on its own. We're building biohybrid grafts that integrate with existing neural circuits, restoring function while preserving what makes you, you.
How It Works
We work end-to-end: from generative AI and biophysical simulations, through in vitro biofabrication, to surgical validation and procedure design. Our platform takes patient brain scans as input, generates cellular-resolution replacement tissue designs, and outputs fabrication instructions. Target applications include tumour resection cavities, stroke lesions, and traumatic brain injuries where neural tissue has been lost.
The biohybrid design does more than restore lost function. It unlocks ultra high bandwidth brain-computer interfaces that conventional electrodes cannot achieve. Traditional BCIs sit on top of neural tissue. Ours becomes part of it. The interface is the substrate.
Our Team
Biohybrid neural tissue sits at the intersection of neuroscience, engineering, and medicine. Our team reflects that: neuroscientists who understand circuit formation, engineers who can design and fabricate grafts, and clinicians who know how to implant them. With backgrounds from ETH/EPFL, Harvard, King's College London, and TU Munich.
Daniel Burger
CEO & Neuroengineer
Michel Wälti
CCO & Neuroscientist
Mahmut Yüksel
CMO & Neurologist
Stefan Dvoretskii
Neural Engineer
Kentaroh Takagaki
Neuroanatomist